Astellas is a pharmaceutical company headquartered in Northbrook, Illinois, United States. It was formed in 2005 through the merger of two Japanese pharmaceutical companies, Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. Astellas' main focus is in the areas of urology, immunology, infectious diseases, oncology, neuroscience, and nephrology.

The company offers a wide range of prescription drugs and medical products to patients, physicians, and healthcare providers. On a global scale, Astellas operates in more than 40 countries and has a presence in Europe, the Americas, Asia, Oceania, and Africa. The company has noteworthy subsidiaries such as Astellas Pharma US, Inc., which is responsible for Astellas' operations in the United States.

Additionally, Astellas has joint ventures and partnerships with other companies to further its research, development, and commercialization efforts. In terms of market position, Astellas is among the top pharmaceutical companies globally. It recorded global sales of approximately $12.

1 billion in the fiscal year ended March 31, 2021. The company faces competition from other major pharmaceutical companies in the industry, but it has successfully established a strong foothold with its innovative products and research capabilities. Astellas has achieved several noteworthy milestones in its growth journey.

In recent years, the company has expanded its product lineup through acquisitions and collaborations. It acquired Audentes Therapeutics in 2019 to strengthen its gene therapy capabilities and entered into a partnership with Pfizer to co-develop and commercialize a diabetes drug. Currently, Astellas continues to focus on innovation and expanding its product portfolio.

It recently received approvals for new drugs in various therapeutic areas, including myelodysplastic syndromes and acute myeloid leukemia. Astellas is actively involved in research and development activities, aiming to provide innovative solutions to unmet medical needs. In conclusion, Astellas is a leading pharmaceutical company headquartered in the United States with a global presence.

It offers a diverse range of pharmaceutical products and services and has established a strong market position in the industry. With its focus on innovation and strategic collaborations, Astellas aims to continue its growth trajectory and contribute to improving global healthcare